Dynaris

Dynaris offers oxygen patients the industry’s newest most innovative oxygen delivery technology. These oxygen products help improve patient health, eliminate oxygen waste, reduce prescription costs, and provide a more comfortable therapeutic experience for those in need.

FDA 510 (K), EUA, ISO-13485 Quality System, FDA registered manufacturing in-house, Ready to go!
5.9 million patients on oxygen in the U.S. alone growing to over 7 million patients in 2023.
Protected by 7 U.S. Patents, more pending, foreign patents pending.
Experienced team with a history of success, from concept through acquisition. CEO has 28 patents.
Superior oxygen therapy for patients. Sets a new therapeutic standard for oxygen patients.
Oxygen therapies are expanding to other areas; i.e. cluster headaches and wound healing treatments.
Additional products in development expand our technologies into other therapeutic market segments.

Alonzo C. Aylsworth, CEO, Managing Member
Conceived products and developed from introduction through acquisition. 28 U.S. patents, many more pending including foreign.

Lawrence C. Spector, Managing Member
Founder of homecare companies that were acquired. Co-Inventor

Timm Eckenroth, Design Engineering Manager
40 years in Engineering/Manufacturing/Design Fields 4 Medical Patents (U.S.)